Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Oxford scientists recognised in prestigious Blavatnik Awards for Young Scientists

Professors Timothy Behrens and Eleanor Stride are recognised this year for their ground-breaking contributions to translational research.

New heart disease drug to be made available to NHS patients through ground-breaking collaboration

Up to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease – a leading cause of death in the UK.

Malnutrition linked with increased risk of Zika birth defects

The severity of Zika virus-related deformations in babies has been shown to be affected by environmental factors such as maternal nutrition.

Oxford University awarded €56 million in European Research Council funding

Oxford University has won the largest amount of new research funding in the UK from the European Research Council (ERC).

Flu antiviral has bigger benefits for sicker, older patients

A Europe-wide study conducted over three flu seasons finds that the antiviral drug, oseltamivir (Tamiflu®), can help people recover from flu-like illness about one-day sooner on average, with older, sicker patients who have been unwell for longer recovering two-to-three days sooner.

Cardiovascular disease remains the leading cause of maternal deaths in the UK

The leading cause of maternal deaths in the UK is still cardiovascular disease, including heart attacks, heart failure and heart rhythm problems, and there has been no reduction in maternal cardiovascular mortality rates for more than 15 years.

New MERS vaccine clinical trial starts in Saudi Arabia

The King Abdullah International Medical Research Centre (KAIMRC), in collaboration with the University of Oxford’s Jenner Institute has started a Phase I clinical trial in the Kingdom of Saudi Arabia (KSA) for a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

New Year's Honours 2020

Members of the University have been recognised in the New Year's Honours list for 2020.

Combined vitamin D and calcium supplements reduce fracture risk

Taking vitamin D and calcium supplements reduces the risk of hip fractures by about one sixth, but taking vitamin D alone does not, according to a new study from the Nuffield Department of Population Health (NDPH) at the University of Oxford.

Building sustainability into traditional Chinese medicine trade on the new Silk Roads

Promoted as a 21st century version of the ancient Silk Roads, China’s Belt & Road Initiative (BRI) aims to improve global connectivity and change the shape of international trade. The multi-billion-dollar project will link China with countries in Southeast and Central Asia, East Africa, Europe and beyond, building a network that will include almost two thirds of the world’s population.

Load More